HD-P023

DRUG3 trials

Sponsors

Handok Inc.

Conditions

Healthy Volunteers

Phase 1

Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

CompletedNCT06339788

Handok Inc.Healthy Volunteers

Start: 2024-05-10End: 2024-06-12Updated: 2025-02-04

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

CompletedNCT06889350

Handok Inc.Healthy Volunteers

Start: 2025-03-26End: 2025-05-07Updated: 2025-07-31

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

CompletedNCT07102719

Handok Inc.Healthy Volunteers

Start: 2025-09-10End: 2025-10-20Updated: 2026-02-05